VCA Specialty Update Symposium

Beyond Hand and Face Transplantation

SUNDAY 24 SEPTEMBER 2017 | 09.00 – 12.50
VCA Specialty Update Symposium


09.00 – 11.00 VCA Session
CHAIRS:  Gerald Brandacher, Baltimore, United States
Emmanuel Morelon, Lyon, France

09:00                      Uterus transplantation: current status and future
                              Mats Brannstrom, Gothenburg, Sweden

09:30                      Penis transplantation: a viable option to restore form and function
                              Frank Graewe, Stellenbosch, South Africa

10:00                      Regenerative medicine and VCA - competitors or perfect couple?
                              Alexandra Iordachescu, Birmingham, United Kingdom

10:30                      Novel technologies for local skin-specific drug delivery
                              Constantin Coussios, Oxford, United Kingdom


11.10 – 12.50 Joint BSC and VCA Session

CHAIRS: Gerald Brandacher, Baltimore, United States
              Nina Pilat-Michalek, Vienna, Austria


11:10                      VCA and regenerative medicine: a perfect couple?
                              Gerald Brandacher, Baltimore, United States

11:20                      Creating stem cell niches in vitro
                              Martin J. Hoogduijn, Rotterdam, The Netherlands

11:50                      Engineering functional tissues: The Holy Grail or an attainable goal?
                              Tahera Ansari, Harrow, United Kingdom

12:20                      Pediatric reconstructive transplantation
                              Lawrence Levin, Philadelphia, United States



VCA in pills:
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This committee brings together 10 representatives of major European teams at the forefront in this field.

Our goal is to raise the scientific and clinical development of Vascularized Composite Allotransplantation (VCA) in Europe and to serve as a platform for scientists and clinicians for information and exchange.




  • Understand the risks and limits of face and upper limb transplantation
  • Discuss and implement new data to characterize chronic rejection
  • Discuss the contribution of animal models in VCA
  • Discuss alternatives strategies  for patients’ management

Target audience:
Surgeons, physicians, researchers, transplant coordinators